Persephone (Drug Discovery) Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$6.3M
- Investors
-
28
Persephone (Drug Discovery) General Information
Description
Developer of equitable precision medicines designed to focus on microbial therapeutics for immuno-oncology applications. The company's medicines use artificial intelligence and omics techniques on multiple cancer patient gut microbiomes and blood samples to identify microbes needed for normal immune function for population-scale patient data analytics, enabling lab researchers to design microbial drugs that prevent and fight cancer.
Contact Information
Website
www.persephonebiosciences.comCorporate Office
- 3210 Merryfield Row
- Suite 5800C
- San Diego, CA 92121
- United States
Corporate Office
- 3210 Merryfield Row
- Suite 5800C
- San Diego, CA 92121
- United States
Persephone (Drug Discovery) Timeline
Persephone (Drug Discovery) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Seed Round | 09-Jan-2024 | $6.3M | Completed | Generating Revenue | ||
5. Secondary Transaction - Private | 01-Oct-2022 | Completed | Generating Revenue | |||
4. Seed Round | 13-Jul-2022 | Completed | Generating Revenue | |||
3. Accelerator/Incubator | 08-Jan-2018 | Completed | Generating Revenue | |||
2. Angel (individual) | 17-Jul-2017 | $200K | $200K | Completed | Startup | |
1. Accelerator/Incubator | 17-Jul-2017 | Completed | Startup |
Persephone (Drug Discovery) Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed-1 | ||||||||
Seed-3 | ||||||||
Seed-2 | 1,044,676 | $0.000100 | $0.02 | $0.22 | $0.22 | 1x | $0.22 | 2.46% |
Persephone (Drug Discovery) Comparisons
Industry
Financing
Details
Persephone (Drug Discovery) Competitors (3)
One of Persephone (Drug Discovery)’s 3 competitors is Eligo Bioscience, a Venture Capital-Backed company based in Paris, France.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
Second Genome | Formerly VC-backed | Brisbane, CA | ||||
MatriSys Bioscience | Venture Capital-Backed | La Jolla, CA |
Persephone (Drug Discovery) Patents
Persephone (Drug Discovery) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230158088-A1 | Compositions for modulating gut microflora populations, enhancing drug potency and treating viral infections, and methods for making and using same | Pending | 26-Mar-2020 | ||
US-20220378855-A1 | Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same | Pending | 20-Dec-2019 | ||
EP-4076482-A1 | Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same | Pending | 20-Dec-2019 | ||
EP-4076482-A4 | Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same | Pending | 20-Dec-2019 | ||
US-D957246-S1 | Collection container | Active | 28-Feb-2019 |
Persephone (Drug Discovery) Signals
Persephone (Drug Discovery) Investors (28)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Mesa Verde Venture Partners | Venture Capital | Minority | ||
Ocampo Capital | Venture Capital | Minority | ||
Rhea Capital Management (Los Angeles) | Venture Capital | Minority | ||
Ayokunle Omojola | Angel (individual) | Minority | ||
Biobrit | Venture Capital | Minority |
Persephone (Drug Discovery) FAQs
-
When was Persephone (Drug Discovery) founded?
Persephone (Drug Discovery) was founded in 2017.
-
Where is Persephone (Drug Discovery) headquartered?
Persephone (Drug Discovery) is headquartered in San Diego, CA.
-
What is the size of Persephone (Drug Discovery)?
Persephone (Drug Discovery) has 21 total employees.
-
What industry is Persephone (Drug Discovery) in?
Persephone (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Persephone (Drug Discovery) a private or public company?
Persephone (Drug Discovery) is a Private company.
-
What is the current valuation of Persephone (Drug Discovery)?
The current valuation of Persephone (Drug Discovery) is
. -
What is Persephone (Drug Discovery)’s current revenue?
The current revenue for Persephone (Drug Discovery) is
. -
How much funding has Persephone (Drug Discovery) raised over time?
Persephone (Drug Discovery) has raised $21.6M.
-
Who are Persephone (Drug Discovery)’s investors?
Mesa Verde Venture Partners, Ocampo Capital, Rhea Capital Management (Los Angeles), Ayokunle Omojola, and Biobrit are 5 of 28 investors who have invested in Persephone (Drug Discovery).
-
Who are Persephone (Drug Discovery)’s competitors?
Eligo Bioscience, Second Genome, and MatriSys Bioscience are competitors of Persephone (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »